Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Equity method investment in Arcus Biosciences, Inc. by Year
Equity method investment in Arcus Biosciences, Inc. — Fair value carrying amount ($M) ($M)
Gilead Sciences Equity method investment in Arcus Biosciences, Inc.: $749M in FY2025, up 67.2% from a year earlier.
Where the FY2025 figure comes from
“|| Equity method investment in Arcus Biosciences, Inc. – fair value option | 969 | 749”
Source: Form 10-Q (gild-20260630.htm, filed 2026-08-06) ↗
Reported in Form 10-Q / 10-K Note 3 Fair Value & Note 4 Equity Securities.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Equity method investment in Arcus Biosciences, Inc. — Fair value carrying amount ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 749 | +67.2% | Form 10-Q (gild-20260630.htm, filed 2026-08-06) ↗ |
| FY2024 | Dec 31, 2024 | 448 | – | Form 10-K (gild-20251231.htm, filed 2026-02-24) ↗ |
| FY2022 | Dec 31, 2022 | 286 | -48.8% | Form 10-Q (gild-20230930.htm, filed 2023-11-07) ↗ |
| FY2021 | Dec 31, 2021 | 559 | +163.7% | Form 10-K (gild-20221231.htm, filed 2023-02-22) ↗ |
| FY2020 | Dec 31, 2020 | 212 | – | Form 10-K (gild-20211231.htm, filed 2022-02-23) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Equity method investment in Arcus Biosciences, Inc. ($M), annual FY2020–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/eq-inv-arcus
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.